医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Korean Food Manufacturer JEJUMAMI Launches Snacks for Kids from Clean Jeju

2019年07月26日 AM11:00
このエントリーをはてなブックマークに追加


 

JEJU, South Korea

To parents who are looking for healthy and reliable foods for their children, JEJUMAMI offers Hokkeullak Chips, grain snacks made by mothers in Jeju, South Korea.

JEJUMAMI’s signature Hokkeullak Chips are puffed grain food snacks made of black barleys from Jeju. It contains Jeju black barley, sun-dried sea salt, and enzyme-treated stevia. Enzyme-treated stevia is a natural sweetener featuring a healthy sweetness with low calories. It can also stabilize blood sugar, making it a good sugar substitute for people with diabetes or on a diet.

The chips do not just provide a great texture and taste but a visual delight with its horse- and hareubang (Jeju’s stone statue) -like figure.

The chips are sold in Innisfree Green Cafe, Jeju Air’s Air Cafe, Caffe Bene, Hyatt Regency Jeju, and Ramada Plaza Jeju. They can also be purchased at online shopping malls such as Market Kurly and Coupang.

The product was selected as Top 10 Must Buy In Jeju 2017 and awarded a grand prize from Korean Processed Rice Food and Traditional Liquor Festival 2018.

JEJUMAMI’s other products, such as Jejubabsim Scorched Rice and Jejubabsang (Jeju local food table) Nutritious Rice, include a variety of foods made by ingredients from Jeju.

“I developed Hokkeullak Chips as a mother who is eager to provide children with healthy food only,” said Kim Jeong-ok, a president of JEJUMAMI. “JEJUMAMI means ‘magical rice from Jeju’ and we will develop processed rice foods made of Jeju’s healthy local ingredients to live up to the name.”

View source version on businesswire.com: https://www.businesswire.com/news/home/20190725005345/en/

CONTACT

For JEJUMAMI Co., Ltd.

ADExpo Korea Co., Ltd.

Jinju Lee, +82-2-6010-1101

adexpo@adexpo.co.kr

同じカテゴリーの記事 

  • KBIバイオファーマ、Jean-Baptiste Agnus氏を最高業務責任者(CBO)に指名
  • 佐賀大学とBostonGeneがEGFR陽性肺癌患者におけるICIの治療効果予測因子を特定するための新規バイオマーカー探索を目的とした研究を発表
  • KBI Biopharma任命Jean-Baptiste Agnus为首席商务官
  • First Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary Syndrome
  • Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024